)
Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Nora Al-Amri (verified customer) Rated 5 out of 5 I didnt run into any technical problems while paying for my order
Heres what we know about its timeline: Current status: Phase 3 clinical trials underway Expected FDA submission: Late 2025 or early 2026 Potential approval: Late 2026 to early 2027, though delays are common Market availability: Likely 2027, assuming trials remain positive If youre interested in accessing retatrutide now, you may be able to join a clinical trial
Compounded semaglutide is prepared by a licensed compounding pharmacy and is not itself an FDA-approved finished drug
For comparison, semaglutide tops out around 15% and tirzepatide around 21%
Patent No.10,278,923 describes the use of GLP-1 peptides in oral therapy
US$ 22.31
US$ 27.52
US$ 26.76
